Literature DB >> 28270263

The intestinal proteome of diabetic and control children is enriched with different microbial and host proteins.

Elsa Pinto1, Marisol Anselmo2, Manuela Calha2, Andrew Bottrill3, Isabel Duarte1, Peter W Andrew4, Maria L Faleiro1.   

Abstract

In this study, the intestinal microbial proteome of children with established type 1 diabetes (T1D) was compared with the proteome of healthy children (Control) with the aim to identify differences in the activity of the intestinal microbiota that not only will contribute to a deeper knowledge of the functionality of the gut in these children but also may provide new approaches to improve the control of the disease. Faecal protein extracts collected from three T1D children (aged 9.3±0.6 years) and three Control children (aged 9.3±1.5 years) were analysed using a combination of 2D gel electrophoresis and spectral counting. The results evidenced markedly differences between the intestinal proteome of T1D children and the Control. The T1D microbial intestinal proteome was enriched with proteins of clostridial cluster XVa and cluster IV and Bacteroides. In contrast, the Control proteome was enriched with bifidobacterial proteins. In both groups, proteins with moonlight function were observed. Human proteins also distinguished the two groups with T1D children depleted in exocrine pancreatic enzymes.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28270263     DOI: 10.1099/mic.0.000412

Source DB:  PubMed          Journal:  Microbiology        ISSN: 1350-0872            Impact factor:   2.777


  23 in total

Review 1.  The crucial role of early-life gut microbiota in the development of type 1 diabetes.

Authors:  He Zhou; Lin Sun; Siwen Zhang; Xue Zhao; Xiaokun Gang; Guixia Wang
Journal:  Acta Diabetol       Date:  2020-07-25       Impact factor: 4.280

2.  Modulation of the immune system by the gut microbiota in the development of type 1 diabetes.

Authors:  James A Pearson; Andrew Agriantonis; F Susan Wong; Li Wen
Journal:  Hum Vaccin Immunother       Date:  2018-09-19       Impact factor: 3.452

Review 3.  Metaproteomics Approach and Pathway Modulation in Obesity and Diabetes: A Narrative Review.

Authors:  Francesco Maria Calabrese; Annalisa Porrelli; Mirco Vacca; Blandine Comte; Katharina Nimptsch; Mariona Pinart; Tobias Pischon; Estelle Pujos-Guillot; Maria De Angelis
Journal:  Nutrients       Date:  2021-12-23       Impact factor: 5.717

4.  Impact of Geographical Location on the Gut Microbiota Profile in Egyptian Children with Type 1 Diabetes Mellitus: A Pilot Study.

Authors:  Nahla M Elsherbiny; Mohammed Ramadan; Nagla H Abu Faddan; Elham Ahmed Hassan; Mohamed E Ali; Abeer Sharaf El-Din Abd El-Rehim; Wael A Abbas; Mohamed A A Abozaid; Ebtisam Hassanin; Ghada A Mohamed; Helal F Hetta; Mohammed Salah
Journal:  Int J Gen Med       Date:  2022-07-15

5.  Intestinal Metaproteomics Reveals Host-Microbiota Interactions in Subjects at Risk for Type 1 Diabetes.

Authors:  Patrick G Gavin; Jane A Mullaney; Dorothy Loo; Kim-Anh Lê Cao; Peter A Gottlieb; Michelle M Hill; Danny Zipris; Emma E Hamilton-Williams
Journal:  Diabetes Care       Date:  2018-08-12       Impact factor: 19.112

6.  An association between chronic widespread pain and the gut microbiome.

Authors:  Maxim B Freidin; Maria A Stalteri; Philippa M Wells; Genevieve Lachance; Andrei-Florin Baleanu; Ruth C E Bowyer; Alexander Kurilshikov; Alexandra Zhernakova; Claire J Steves; Frances M K Williams
Journal:  Rheumatology (Oxford)       Date:  2021-08-02       Impact factor: 7.580

7.  Impact of type 1 diabetes on the composition and functional potential of gut microbiome in children and adolescents: possible mechanisms, current knowledge, and challenges.

Authors:  Pari Mokhtari; Julie Metos; Pon Velayutham Anandh Babu
Journal:  Gut Microbes       Date:  2021 Jan-Dec

8.  TRIF deficiency protects non-obese diabetic mice from type 1 diabetes by modulating the gut microbiota and dendritic cells.

Authors:  Elke Gülden; Chen Chao; Ningwen Tai; James A Pearson; Jian Peng; Monika Majewska-Szczepanik; Zhiguang Zhou; F Susan Wong; Li Wen
Journal:  J Autoimmun       Date:  2018-06-28       Impact factor: 7.094

Review 9.  Dysbiosis in the Development of Type I Diabetes and Associated Complications: From Mechanisms to Targeted Gut Microbes Manipulation Therapies.

Authors:  Gratiela Gradisteanu Pircalabioru; Nicolae Corcionivoschi; Ozan Gundogdu; Mariana-Carmen Chifiriuc; Luminita Gabriela Marutescu; Bogdan Ispas; Octavian Savu
Journal:  Int J Mol Sci       Date:  2021-03-09       Impact factor: 5.923

Review 10.  Evaluating the Causal Role of Gut Microbiota in Type 1 Diabetes and Its Possible Pathogenic Mechanisms.

Authors:  He Zhou; Lin Sun; Siwen Zhang; Xue Zhao; Xiaokun Gang; Guixia Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2020-03-24       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.